A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for blockbuster ...
Tirzepatide demonstrated superior cost-effectiveness compared to semaglutide for knee OA and obesity, with a $57,400 per QALY threshold. The Osteoarthritis Policy Model assessed cost-effectiveness, ...
A new study confirms that naloxone, also known as Narcan, is an evidence-based, cost-effective way to prevent overdose deaths ...
A 2-step decision analytic model consisting of a decision tree-informed Markov structure was used to estimate lifetime outcomes in older patients with prostate cancer. The P-score reclassifies a ...
Animals are going extinct at an alarmingly fast rate, largely due to human activity. Same for plants. This is bad for all kinds of reasons, not least of which is that breakthrough drugs often come ...
Usual care provided 9.59 QALYs at a lifetime cost of $222,300, diet and exercise yielded 9.75 QALYs for $226,300, and semaglutide offered 10.48 QALYs at $273,500, with tirzepatide providing 10.68 ...
A new UCLA Health study found that taking an 8-strain probiotic daily may reduce the risk of pouchitis, a common inflammatory condition that occurs after colon removal surgery for ulcerative colitis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback